Andy Goren Selected Research

Androgen Receptor Antagonists

2/2021	Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial.
2/2021	Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical).
1/2021	Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andy Goren Research Topics

Disease

20	Alopecia (Baldness) 01/2022 - 03/2011
16	COVID-19 08/2022 - 01/2020
6	Vitiligo 01/2020 - 03/2014
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 03/2014
2	Acne Vulgaris 07/2021 - 01/2021
2	Infections 11/2020 - 07/2020
1	Rosacea (Acne Rosacea) 05/2022
1	Pain (Aches) 04/2022
1	Atopic Dermatitis (Atopic Eczema) 04/2022
1	Inflammation (Inflammations) 04/2022
1	Reinfection 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 07/2021
1	Hirsutism 07/2021
1	Anosmia 02/2021
1	Fatigue 02/2021
1	Hyperandrogenism 01/2021
1	Eczema 01/2021
1	Virus Diseases (Viral Diseases) 11/2020
1	Human Influenza (Influenza) 11/2020
1	Hypertension (High Blood Pressure) 10/2020
1	Obesity 10/2020
1	Severe Acute Respiratory Syndrome 10/2020
1	Prostatic Neoplasms (Prostate Cancer) 07/2020
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Glaucoma 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Psoriatic Arthritis 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Pruritus (Itching) 03/2016
1	Erythema 07/2014

Drug/Important Bio-Agent (IBA)

14	AndrogensIBA 08/2022 - 07/2020
9	Minoxidil (Rogaine)FDA LinkGeneric 01/2022 - 05/2014
7	Pharmaceutical PreparationsIBA 12/2021 - 05/2014
6	Androgen Receptors (Androgen Receptor)IBA 08/2022 - 03/2011
4	proxalutamideIBA 12/2021 - 01/2021
4	SulfotransferasesIBA 01/2020 - 07/2014
3	Androgen Antagonists (Antiandrogens)IBA 02/2021 - 11/2020
3	Androgen Receptor AntagonistsIBA 02/2021 - 01/2021
3	Serine Proteases (Serine Protease)IBA 02/2021 - 10/2020
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 01/2020
2	Antihypertensive Agents (Antihypertensives)IBA 10/2020 - 01/2020
2	EnzymesIBA 01/2019 - 11/2018
1	Aspartame (NutraSweet)IBA 04/2022
1	CannabidiolIBA 04/2022
1	VaccinesIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Oxandrolone (Anavar)FDA LinkGeneric 02/2021
1	Anabolic Androgenic SteroidsIBA 02/2021
1	Proteins (Proteins, Gene)FDA Link 02/2021
1	Dutasteride (Avodart)FDA Link 02/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2021
1	nitazoxanide (NTZ)FDA Link 02/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	COVID-19 vaccine booster shotIBA 01/2021
1	Oral ContraceptivesIBA 01/2021
1	MelatoninIBA 11/2020
1	Viral VaccinesIBA 11/2020
1	angiotensin I (1-7)IBA 10/2020
1	Hormones (Hormone)IBA 10/2020
1	MineralocorticoidsIBA 10/2020
1	AngiotensinsIBA 10/2020
1	Angiotensin IIIBA 10/2020
1	VemurafenibIBA 01/2020
1	Latanoprost (Xalatan)FDA Link 01/2020
1	cobimetinibIBA 01/2020
1	DinoprostIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	RetinoidsIBA 01/2019
1	minoxidil sulfotransferaseIBA 11/2018
1	tofacitinibIBA 01/2018
1	Janus Kinase InhibitorsIBA 01/2018
1	bioskinIBA 01/2018
1	Ficusin (Psoralen)IBA 03/2014
1	Finasteride (Propecia)FDA LinkGeneric 03/2011
1	5-alpha Reductase InhibitorsIBA 03/2011

Therapy/Procedure

14	Therapeutics 05/2022 - 03/2011
6	Phototherapy (Light Therapy) 01/2018 - 03/2014
2	Traction 01/2019 - 05/2016
1	Lasers (Laser) 05/2022
1	Length of Stay 12/2021
1	Secondary Prevention 02/2021
1	Low-Level Light Therapy (LLLT) 08/2020
1	Immunotherapy 01/2020
1	Aftercare (After-Treatment) 01/2019